The MAPK/ERK signaling pathway is an additional critical target for inhibitors. Inhibitors targeting MAPK/ERK are utilized in cancer treatments to prevent uncontrolled cell spreading and lump growth.Antibiotics are a part of inhibitors that have changed the administration of bacterial infections. By targeting bacterial cell walls, protein synthesis